{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:38:22Z","timestamp":1772203102521,"version":"3.50.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R00 HL105663"],"award-info":[{"award-number":["R00 HL105663"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL133433"],"award-info":[{"award-number":["R01 HL133433"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["RO1 HL114085"],"award-info":[{"award-number":["RO1 HL114085"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["RO1 HL131626"],"award-info":[{"award-number":["RO1 HL131626"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL110551"],"award-info":[{"award-number":["R01 HL110551"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197105","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T13:34:08Z","timestamp":1526304848000},"page":"e0197105","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells"],"prefix":"10.1371","volume":"13","author":[{"given":"Blanca E.","family":"Himes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kseniya","family":"Obraztsova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lurong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Shumyatcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Rue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena N.","family":"Atochina-Vasserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella K.","family":"Hur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa S.","family":"Bartolomei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilly F.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0584-4486","authenticated-orcid":true,"given":"Vera P.","family":"Krymskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"RA Saxton","year":"2017","journal-title":"Cell"},{"key":"ref2","article-title":"Game of TOR\u2014The Target of Rapamycin Rules Four Kingdoms","author":"BD Manning","year":"2017","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene <italic>TSC2<\/italic> are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"T Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis","volume":"277","author":"EA Goncharova","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-med-050715-104245","article-title":"Lymphangioleiomyomatosis: A Monogenic Model of Malignancy","volume":"68","author":"VP Krymskaya","year":"2017","journal-title":"Annual Review of Medicine"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI58709","article-title":"Lymphangioleiomyomatosis\u2014a wolf in sheep\u2019s clothing","volume":"122","author":"EP Henske","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"SR Johnson","year":"2010","journal-title":"Eur Respir J"},{"issue":"67","key":"ref8","first-page":"1","article-title":"The Pharmacology of mTOR Inhibition. Sci Signal","volume":"2","author":"DA Guertin","year":"2009","journal-title":"The Pharmacology of mTOR Inhibition. Sci Signal"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis","volume":"358","author":"JJ Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis","volume":"364","author":"FX McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/MCB.01061-10","article-title":"mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells","volume":"31","author":"EA Goncharova","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1164\/rccm.201411-2032ED","article-title":"Chronic Sirolimus Therapy for Lymphangioleiomyomatosis","volume":"190","author":"FX McCormack","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"R321","DOI":"10.1530\/ERC-13-0231","article-title":"IGF2 and cancer","volume":"20","author":"C Livingstone","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tibs.2009.07.003","article-title":"Keeping IGF-II under control: Lessons from the IGF-II\u2013IGF2R crystal structure","volume":"34","author":"J Brown","year":"2009","journal-title":"Trend Biochem Sci"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2310\/6650.2001.33787","article-title":"Distribution and mRNA Expression of Insulin-Like Growth Factor System in Pulmonary Lymphangioleiomyomatosis","volume":"49","author":"JC Valencia","year":"2015","journal-title":"Journal of Investigative Medicine"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"H Zhang","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways","volume":"286","author":"J Yu","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"NL Bray","year":"2016","journal-title":"Nat Biotechnol"},{"key":"ref19","year":"2016"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"DW Huang","year":"2008","journal-title":"Nat Protocols"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"A Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"ref22","article-title":"Humanized H19\/Igf2 locus reveals diverged imprinting mechanism between mouse and human and reflects Silver-Russell Syndrome phenotypes","author":"SK Hur","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.celrep.2014.03.025","article-title":"Folliculin Controls Lung Alveolar Enlargement and Epithelial Cell Survival through E-Cadherin, LKB1, and AMPK","volume":"7","author":"A Goncharova Elena","year":"2014","journal-title":"Cell Reports"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2353\/ajpath.2010.091239","article-title":"Lymphangioleiomyoma Cells and Lymphatic Endothelial Cells: Expression of VEGFR-3 in Lymphangioleiomyoma Cell Clusters","volume":"176","author":"K Seyama","year":"2010","journal-title":"Am J Pathol"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cytogfr.2008.01.005","article-title":"IGF2: Epigenetic regulation and role in development and disease","volume":"19","author":"W Chao","year":"2008","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1387\/ijdb.140077mb","article-title":"Epigenetics and imprinting in human disease","volume":"58","author":"JM Kalish","year":"2014","journal-title":"Int J Dev Biol"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"H Yu","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1124\/mol.109.057042","article-title":"Signal Transducer and Activator of Transcription 3 Is Required for Abnormal Proliferation and Survival of TSC2-Deficient Cells: Relevance to Pulmonary Lymphangioleiomyomatosis","volume":"76","author":"EA Goncharova","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/onc.2008.448","article-title":"The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-[beta] signaling","volume":"28","author":"L Lin","year":"2009","journal-title":"Oncogene"},{"issue":"18","key":"ref30","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1073\/pnas.0609757104","article-title":"Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity","volume":"104","author":"K Siddiquee","year":"2007","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ebiom.2016.11.035","article-title":"Paternal Insulin-like Growth Factor 2 (Igf2) Regulates Stem Cell Activity During Adulthood","volume":"15","author":"V Barroca","year":"2017","journal-title":"EBioMedicine"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1242\/dev.054916","article-title":"Impaired mesenchymal stem cell differentiation and osteoclastogenesis in mice deficient for Igf2-P2 transcripts","volume":"138","author":"SN Hardouin","year":"2011","journal-title":"Development"},{"issue":"49","key":"ref33","doi-asserted-by":"crossref","first-page":"34029","DOI":"10.1074\/jbc.M803012200","article-title":"JAK2\/STAT2\/STAT3 Are Required for Myogenic Differentiation","volume":"283","author":"K Wang","year":"2008","journal-title":"J Biol Chem"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ncb3111","article-title":"Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway","volume":"17","author":"J-S Mo","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/emmm.201201509","article-title":"IGF2: the Achilles&apos; heel of p53-deficiency?","volume":"4","author":"F Clermont","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/emmm.201101105","article-title":"Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes","volume":"4","author":"VL Haley","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"22","key":"ref37","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM198812013192202","article-title":"Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia","volume":"319","author":"WH Daughaday","year":"1988","journal-title":"N Engl J Med"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/modpathol.2009.48","article-title":"Expression of insulin-like growth factor 2 in mesenchymal neoplasms","volume":"22","author":"SE Steigen","year":"2009","journal-title":"Mod Pathol"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/0008-5472.CAN-15-1287","article-title":"Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation","volume":"76","author":"J D'Armiento","year":"2016","journal-title":"Cancer Res"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1359-6101(96)00053-6","article-title":"Insulin-like growth factor binding proteins and their role in controlling IGF actions","volume":"8","author":"DR Clemmons","year":"1997","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"M Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1101\/gad.209130.112","article-title":"mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts","volume":"27","author":"N Dai","year":"2013","journal-title":"Gene Develop"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1101\/gad.2042311","article-title":"mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry","volume":"25","author":"N Dai","year":"2011","journal-title":"Gene Develop"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cmet.2015.03.006","article-title":"IGF2BP2\/IMP2-Deficient mice resist obesity through enhanced translation of Ucp1 mRNA and Other mRNAs encoding mitochondrial proteins","volume":"21","author":"N Dai","year":"2015","journal-title":"Cell Metab"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncb3311","article-title":"Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling","volume":"18","author":"M Ding","year":"2016","journal-title":"Nat Cell Biol"},{"issue":"22","key":"ref46","doi-asserted-by":"crossref","first-page":"36628","DOI":"10.18632\/oncotarget.16695","article-title":"Insulin growth factor binding protein 2 mediates the progression of lymphangioleiomyomatosis","volume":"8","author":"X Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref47","article-title":"Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies","author":"A Simpson","year":"2017","journal-title":"Targeted Oncology"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/1535-7163.MCT-13-0598","article-title":"Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin","volume":"13","author":"K Friedbichler","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"15_suppl","key":"ref49","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1200\/JCO.2016.34.15_suppl.530","article-title":"Phase 1b\/2 trial of BI 836845, an insulin-like growth factor (IGF) ligand-neutralizing antibody, combined with exemestane (Ex) and everolimus (Ev) in hormone receptor-positive (HR+) locally advanced or metastatic breast cancer (BC): primary phase 1b results","volume":"34","author":"J Cortes","year":"2016","journal-title":"Journal of Clinical Oncology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T18:41:52Z","timestamp":1604256112000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197105"}},"subtitle":[],"editor":[{"given":"Carol","family":"Feghali-Bostwick","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197105","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.17504\/protocols.io.njqdcmw","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]}}}